Navigation Links
Cedars-Sinai Medical Center to Use Exosome Diagnostics Exosome RNA Biofluid Kits in Neo-Natal Setting and Cancer for Development of Personalized Medicine Diagnostics
Date:9/30/2013

NEW YORK, Sept. 30, 2013 /PRNewswire/ -- Exosome Diagnostics today announced that it has selected Cedars-Sinai Medical Center to participate in an early technology access program for use of exosome RNA biofluid extraction kits for biomarker discovery in neo-natal and other disease settings.  

"The ability to monitor patients, particularly extreme premature infants, using real-time biofluid based genetics tests, may provide critical information which is currently unavailable, said Charles F. Simmons, M.D., professor and chair of Cedars-Sinai's Department of Pediatrics. "We have been interested in exosome biology as a tool for diagnostic development, and are pleased to be selected to have access for our neonatal patients to this novel technology for biomarker discovery."

James McCullough, chief executive officer of Exosome Diagnostics said, "Partnering with clinical leaders such as Dr. Simmons and his team at Cedars-Sinai's Maxine Dunitz Children's Health Center is a high priority as we move to validate our blood RNA kits where precision monitoring of gene expressions is important to understanding effectiveness of drug therapy."

Dolores Di Vizio, M.D., Ph.D., associate professor of Surgery and an expert on blood-based biomarkers in microvesicles, who works with Vincent Funari, Ph.D., director of the Cedars-Sinai genomics core commented, "Having the opportunity to join with Dr. Simmons' initiative and apply the Exosome Diagnostics kit technology for biomarker discovery and next generation sequencing applications in clinical oncology samples will facilitate our efforts toward Precision Medicine and tailored therapy for prostate cancer. They will work together and in close collaboration with Dr. Michael Freeman, PhD, director of the Cancer Biology Program at the Samuel Oschin Comprehensive Cancer Institute."

The Exosome Center of Excellence program is designed to allow clinical centers already performing clinical research on blood based biomarkers in exosomes early access to the EXO50 exosome isolation and extraction technology, ahead of commercial launch. The goals of the early access program are to gain feedback from the clinical research community on the performance of the EXO50 kit, while generating clinically relevant data that can used immediately in the research setting.

Exosome Diagnostics rapid isolation and extraction technology produces high-quality RNA and DNA, including full length mRNA and microRNA, from patient blood (serum and plasma), for analysis by standard PCR, array, and sequencing instruments. Exosome Diagnostics proprietary technology, under development as EXO50, will enable clinicians to perform real-time biomarker analysis on patient plasma and serum samples, allowing for the advancement of personalized medicine. Exosome Diagnostics recently announced a partnership with QIAGEN for global commercialization of clinical research kits for extraction of RNA from biofluid exosomes, starting in 2014.

About Exosome Diagnostics
Exosome Diagnostics is a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes are packaged and shed into all biofluids, including blood, urine and CSF, providing a stable source for intact, cell-specific nucleic acids. The company's proprietary exosome technology makes use of the presence and natural stability of RNA in exosomes to detect and measure levels of genes responsible for cancer and other diseases. The company is commercializing in vitro diagnostic tests for use in companion diagnostic applications and real-time monitoring of disease. For more information, please visit www.exosomedx.com.


'/>"/>
SOURCE Exosome Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cedars-Sinai researchers, with stem cells and global colleagues, develop Huntingtons research tool
2. Cedars-Sinai Medical Center Recovers More Than $300 million in AR with Hyland Softwares OnBase
3. Discovery Meets Recovery in New Cedars-Sinai’s Advanced Health Sciences Pavilion Designed by HOK
4. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
5. DiaTech Life Sciences Announces Medical Advisory Board
6. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
7. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
8. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
9. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
10. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
11. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... May 27, 2016 At present, the ... in this space know that volatility is what makes this ... on ActiveWallSt.com: Synta Pharmaceuticals Corp. (NASDAQ: SNTA ), ... (NASDAQ: LPTN ), and Heat Biologics Inc. (NASDAQ: ... to the technical alerts for these stocks at: ...
(Date:5/26/2016)... and READING, England , ... ( http://www.indegene.com ), a leading global provider of ... pharmaceutical and healthcare organisations and TranScrip ( http://www.transcrip-partners.com ... support throughout the product lifecycle, today announced the ... of IntraScience.      (Logo: http://photos.prnewswire.com/prnh/20141208/720248 ...
(Date:5/26/2016)... May 26, 2016 Despite the volatility ... in this space. Today,s pre-market research on ActiveWallSt.com directs the ... Inc. (NASDAQ: RDUS ), Cerus Corp. (NASDAQ: ... ), and Five Prime Therapeutics Inc. (NASDAQ: FPRX ... at: http://www.activewallst.com/ On Wednesday, ...
(Date:5/26/2016)... CA (PRWEB) , ... May 26, 2016 , ... ... and manufacturing company, today announced several positive developments that position the Company for ... a result of the transaction, Craig F. Kinghorn has been appointed Chairman of ...
Breaking Biology Technology:
(Date:3/15/2016)... , March 15, 2016 ... report published by Transparency Market Research "Digital Door Lock Systems ... Forecast 2015 - 2023," the global digital door lock systems ... Mn in 2014 and is forecast to grow at a ... of micro, small and medium enterprises (MSMEs) across the world ...
(Date:3/11/2016)... Germany , March 11, 2016 http://www.apimages.com ... - Cross reference: Picture is available at AP Images ( http://www.apimages.com ... from DERMALOG will be used to produce the new refugee identity ... other biometric innovations, at CeBIT in Hanover ... scanner from DERMALOG will be used to produce the new refugee ...
(Date:3/9/2016)... NEW YORK , March 9, 2016 ... current and future states of the RNA Sequencing (RNA ... in segments such as instruments, tools and reagents, data ... Analyze various segments of the RNA-Sequencing market such ... RNA-Sequencing services Identify the main factors affecting each segment ...
Breaking Biology News(10 mins):